Effect of Omidenepag Eye Drop on Optic Nerve Head Microcirculation, Shape of Optic Disc and Visual Field.

Effect of Omidenepag Eye Drop on Optic Nerve Head Microcirculation, Shape of Optic Disc and Visual Field. - Omidenepag Eye Drop and Optic Nerve Head Microcirculation, Shape of Optic Disc and Visual Field.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040222

Enrollment

Registered

2020-04-23

Start date

2020-02-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open Angle Glaucoma

Interventions

Omidenepag Administration for 3 Moths and Latanoprost for 12 moths Latanoprost for 3 Moths and Omidenepag Administration for 12 moths Omidenepag Administration for 12 moths

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with Primary Open Angle Glaucoma Including Normal Tension Glaucoma and Laser Speckle Flowgraphy, Optical Coherence Tomography Angiography and Visual Field are measurable.

Exclusion criteria

Exclusion criteria: Patient with Ocular Eye Disease Except for Glaucoma, High Myopia ( more than 6D ), Systemic Diseases which Treatment influences Ocular Blood Flow, Ocular Opacity witch interrupt Ocular Funds Observation, Allergy to Omidenepag

Design outcomes

Primary

Measure	Time frame
Optic Nerve Head Microcirculation (Before and 3, 6, 12 Month after administration )	—

Secondary

Measure	Time frame
Intraocular Pressure, Blood Pressure, Pulse Rate, Shape of Optic, Disc, Humphrey Visual Field (Before and 3, 6, 12 Month after administration )	—

Countries

Japan

Contacts

Public ContactAKIKAZU SUMINO

Osaka Medical and Pharmaceutical University Deparment of Ophthalmology

akikazu121@kcn.jp+81-72-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026